Yujiro S. Hata

Insider Reports History

Location
Monrovia, CA
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yujiro S. Hata:

Form 4 holding President and CEO, Director

IDEAYA Biosciences, Inc.

Security class
Common Stock
Shares / value
690,695
Estimated value
$13,482,366
Report date
18 Feb 2025
Price
$19.52
Ownership
Direct
Form 4 holding President and CEO, Director

IDEAYA Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
600,000
Estimated value
Report date
30 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Xencor Inc

Security class
Stock Option (Right to Buy)
Shares / value
21,412
Estimated value
Report date
23 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Yujiro S. Hata

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .